Medication info
Aspido Capsule

Aspido Capsule

Prescription medicationHard capsule
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 capsuleAspirin Enteric Pellets›122mg / 1 capsule
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
A hard capsule with a lower and upper orange casing containing white or pale yellow granules and enteric-coated pellets.
Packaging
30 capsules/bottle, 300 capsules/bottle
Approval status
Active

MFDS item code 201605650 · Approved 2016.09.26 · Insurance code 693201720

Summary

Main use
Improvement of symptoms of acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who uses it
Adults
Adult dosage
Administer 1 capsule once daily.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • atherosclerotic symptoms
  • cardiovascular disorders
  • myocardial infarction
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
  • atherothrombosis
View approved original text

This medication is used for patients with acute coronary syndrome who have unstable angina or non-Q-wave myocardial infarction, or who have undergone or are scheduled for coronary intervention (including stenting) or coronary artery bypass grafting. It helps to improve outcomes related to cardiovascular death, myocardial infarction, stroke, or blood circulation problems in these patients. Additionally, this medication is used to reduce the risk of stroke and thrombosis in atrial fibrillation patients at low risk of bleeding, where vitamin K antagonist therapy is not suitable and vascular risk factors are present. In other words, this drug is effectively used to protect heart and vascular health and reduce cardiovascular-related risks.

Dosage and Administration

Adult dosage

Administer 1 capsule once daily.

Precautions

This medication prevents the blood from clotting to avoid thrombosis. However, taking this medication may prolong the time it takes for bleeding to stop, so patients should immediately inform their doctor if they experience severe or prolonged bleeding. Always inform healthcare providers about taking this medication before surgery or starting new medications. People genetically predisposed to decreased function of the specific enzyme (CYP2C19) may experience reduced efficacy of this medication and may have more frequent cardiovascular issues, so caution is advised. Additionally, it is advisable to avoid taking this medication with other drugs that increase the activity of this enzyme, as there is a potential risk of increased bleeding. Individuals who consume multiple alcoholic beverages daily should consult with a doctor or pharmacist before taking this medication because combining it with alcohol may increase the risk of gastrointestinal bleeding. This medication may cause allergic reactions, so individuals with hypersensitivity, asthma, allergic rhinitis, or allergies to certain anti-inflammatory drugs should not take it. Also, those with peptic ulcers, intracranial hemorrhage, hemophilia, or severe liver or kidney dysfunction should avoid taking this medication. Patients with a history of gastrointestinal bleeding or bleeding tendencies should exercise caution, and if bleeding symptoms emerge during treatment, they must promptly inform their healthcare provider. If surgery is planned, the use of this medication should be discontinued 5-7 days prior, and it should be resumed only after hemostasis has been achieved. The safety of this medication in children and adolescents has not been established, and it is not recommended for individuals under 18 years of age. Due to the risk of bleeding, special caution should be exercised when combining it with other anticoagulants. In particular, the risk of bleeding may increase when taken with warfarin, non-steroidal anti-inflammatory drugs, or selective serotonin reuptake inhibitors (SSRIs). This medication should not be taken during pregnancy, especially in the third trimester, and should be avoided during breastfeeding as well. Possible adverse effects include bleeding, skin rash, gastrointestinal symptoms, blood abnormalities, etc., so if any of these symptoms occur, the patient should consult their healthcare provider immediately.

Side effects

Abnormal bleeding, gastrointestinal bleeding, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular bleeding, intracranial hemorrhage, hemorrhagic stroke, hemorrhagic arthropathy, thrombocytopenia, impaired platelet function, pancytopenia, agranulocytosis, aplastic anemia, neutropenia, diarrhea, abdominal pain, dyspepsia, nausea, vomiting, rash, pruritus, angioedema, urticaria, rhinitis, conjunctivitis, fixed drug eruption, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), LIEL syndrome, Stevens-Johnson syndrome, exfoliative dermatitis, shock, anaphylactic symptoms, loss of appetite, heartburn, stomach pain, tinnitus, hearing loss, dizziness, headache, agitation, elevated liver enzymes, liver damage, chronic hepatitis, renal impairment, acute renal failure, hyperventilation, metabolic acidosis, confusion, hallucinations, taste disturbances, loss of taste, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, maculopapular rash, erythematous rash, urticaria, pruritus, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eczema, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, gynecomastia, fever, abnormal liver function tests, increased serum creatinine, reduced exercise capacity, tremor, voice disorders, abnormal gait, hyperkinesia, ataxia, sensory disturbances, constipation, nausea, ulcer, loss of appetite, vomiting, hiccups, dry mouth, dysphagia, tongue disorders, insomnia, depression, forgetfulness, anxiety, hypersomnia, abnormal thinking, abnormal behavior, weight loss, weight gain, facial flushing, weakness, rigidity, facial swelling, syncope, purpura, hematochezia, thrombocytopenia, pneumonia, sinusitis, visual disturbances, field defects, dry eye syndrome, temporary blindness, congestion, tinnitus, urinary disorders, frequency of urination, non-protein nitrogen increase, uremia, increase in blood urea nitrogen, hypoglycemia, hyperuricemia, elevated liver enzymes, increased SGPT, leg edema, arrhythmia, bradycardia, palpitations, contact dermatitis, gynecomastia, elevated PSA

Not everyone experiences these, and they can vary from person to person.

Storage

Keep this medication in a tightly closed container to prevent air or moisture from entering. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

A hard capsule with a lower and upper orange casing containing white or pale yellow granules and enteric-coated pellets.

Package unit

30 capsules/bottle, 300 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.